TY - JOUR
T1 - Guidelines for the primary prevention of stroke
T2 - A statement for healthcare professionals from the American heart association/American stroke association
AU - American Heart Association Stroke Council
AU - Council on Cardiovascular and Stroke Nursing
AU - Council on Clinical Cardiology
AU - Council on Functional Genomics and Translational Biology
AU - Council on Hypertension
AU - Meschia, James F.
AU - Bushnell, Cheryl
AU - Boden-Albala, Bernadette
AU - Braun, Lynne T.
AU - Bravata, Dawn M.
AU - Chaturvedi, Seemant
AU - Creager, Mark A.
AU - Eckel, Robert H.
AU - Elkind, Mitchell S.V.
AU - Fornage, Myriam
AU - Goldstein, Larry B.
AU - Greenberg, Steven M.
AU - Horvath, Susanna E.
AU - Iadecola, Costantino
AU - Jauch, Edward C.
AU - Moore, Wesley S.
AU - Wilson, John A.
N1 - Publisher Copyright:
© 2014 American Heart Association, Inc.
PY - 2014/12/11
Y1 - 2014/12/11
N2 - The aim of this updated statement is to provide comprehensive and timely evidence-based recommendations on the prevention of stroke among individuals who have not previously experienced a stroke or transient ischemic attack. Evidencebased recommendations are included for the control of risk factors, interventional approaches to atherosclerotic disease of the cervicocephalic circulation, and antithrombotic treatments for preventing thrombotic and thromboembolic stroke. Further recommendations are provided for genetic and pharmacogenetic testing and for the prevention of stroke in a variety of other specific circumstances, including sickle cell disease and patent foramen ovale.
AB - The aim of this updated statement is to provide comprehensive and timely evidence-based recommendations on the prevention of stroke among individuals who have not previously experienced a stroke or transient ischemic attack. Evidencebased recommendations are included for the control of risk factors, interventional approaches to atherosclerotic disease of the cervicocephalic circulation, and antithrombotic treatments for preventing thrombotic and thromboembolic stroke. Further recommendations are provided for genetic and pharmacogenetic testing and for the prevention of stroke in a variety of other specific circumstances, including sickle cell disease and patent foramen ovale.
KW - AHA Scientific Statements
KW - Atrial fibrillation
KW - Diabetes mellitus
KW - Hyperlipidemias
KW - Hypertension
KW - Intracranial aneurysm
KW - Ischemia
KW - Prevention and control
KW - Smoking
KW - Stroke
UR - http://www.scopus.com/inward/record.url?scp=84918581493&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84918581493&partnerID=8YFLogxK
U2 - 10.1161/STR.0000000000000046
DO - 10.1161/STR.0000000000000046
M3 - Article
C2 - 25355838
AN - SCOPUS:84918581493
SN - 0039-2499
VL - 45
SP - 3754
EP - 3832
JO - Stroke
JF - Stroke
IS - 12
ER -